Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5578154 | 6482152 | F | 5578154-3 | 20071220 | 20071231 | EXP | CH-PFIZER INC-2007099620 | PFIZER INC | 70 | YR | M | Y | 73 | KG | 20071231 | MD | SWITZERLAND |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5578154 | 1009350741 | PS | SORTIS | 2 | ORAL | 20702 | |||||
| 5578154 | 1009350742 | SS | SORTIS | 2 | 020702 | ||||||
| 5578154 | 1009350743 | SS | EZETROL | 2 | ORAL | ||||||
| 5578154 | 1009350744 | SS | EZETROL | 2 | |||||||
| 5578154 | 1009350745 | C | MICARDIS | 1 | ORAL | DAILY DOSE:80MG-FREQ:DAILY | |||||
| 5578154 | 1009350746 | C | LISIPRIL | 2 | ORAL | DAILY DOSE:5MG-FREQ:DAILY | |||||
| 5578154 | 1009350747 | C | NORVASC | 1 | ORAL | DAILY DOSE:5MG-FREQ:DAILY |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 5578154 | 1009350741 | HYPERCHOLESTEROLAEMIA |
| 5578154 | 1009350742 | PERIPHERAL ARTERIAL OCCLUSIVE DISEASE |
| 5578154 | 1009350743 | HYPERCHOLESTEROLAEMIA |
| 5578154 | 1009350744 | PERIPHERAL ARTERIAL OCCLUSIVE DISEASE |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 5578154 | OT |
Reactions reported
| Event ID | PT |
|---|---|
| 5578154 | FORMICATION |
| 5578154 | MUSCLE ATROPHY |
| 5578154 | MUSCLE SPASMS |
| 5578154 | NEUROPATHY PERIPHERAL |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 5578154 | 1009350746 | 20050101 | |||
| 5578154 | 1009350747 | 20050101 |